According to FutureWise analysis the market for cell cryopreservation in 2023 was US$ 10.61 billion, and is expected to reach US$ 54.21 billion by 2031 at a CAGR of 22.60%.
Cell cryopreservation is a specialized technique employed to cool and preserve living cells at extremely low temperatures, ensuring their viability and functionality for subsequent use. This process involves the addition of a cryoprotective agent to safeguard the cells against potential damage during freezing. Following this, the cells are gradually cooled to temperatures typically below -150°C, effectively halting all metabolic activity. The frozen cells can be stored for extended periods and are later thawed for various applications, including research, medical treatments, and biotechnological pursuits.
Cryopreservation is particularly valuable for maintaining rare and valuable cell types that are challenging to sustain in culture. The market for cell cryopreservation is influenced by the growing demand for personalized medicine, regenerative therapies, and stem cell research, all of which necessitate the preservation of high-quality cell samples for future utilization. The biobanking sector plays a pivotal role in this market, driven by an increasing need for superior cell samples for both research and clinical applications. Furthermore, the pharmaceutical and biotechnology industries are significant consumers of cell cryopreservation services, as they require high-quality cell lines for drug discovery and development. Looking ahead, the continuous development of innovative cryopreservation techniques along with the integration of automation and robotics is anticipated to contribute to the market's growth in the coming years.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=12167%20&type=requestsample
Cell Cryopreservation Market Segmentation:
By Product Type
- Cryoprotectant Agents
- Glycerol
- Dimethyl Sulfoxide (DMSO)
- Others
- Equipment
- Incubators
- Liquid Nitrogen Supply Tanks
- Freezers
- Others
By Application
- Stem Cells
- Oocytes and Embryos
- Sperm, Semen, and Testicular Tissue
- Hepatocytes
- Others
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Biobank
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Cell Cryopreservation Market:
- General Electric Company
- Thermo Fisher Scientific Inc.
- Merck KGaA
- AMS Biotechnology Limited
- Miltenyi Biotec GmbH
- BioLifeSolutions Inc.
- HiMedia Laboratories Pvt. Ltd.
- PromoCell GmbH
- Corning Incorporated
- Cooper Companies, Inc.
- Planer PLC
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=12167&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Cell Cryopreservation Market By Product Type, By Application, By End User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
